−447 KRW
−53.46 B KRW
0.00 KRW
96.45 M
About NEOIMMUNETECH, INC.
Sector
Industry
CEO
Luke Oh
Website
Headquarters
Rockville
Founded
2014
ISIN
KR8840140006
FIGI
BBG00YT9C180
NeoImmuneTech, Inc. is a clinical-stage biopharmaceutical company. which engages in the development of T cell-centered novel immunotherapeutics. The firm develops its product NT-I7 for the treatment of lymphopenia. The company was founded by Se Hwan Yang in January 2014 and is headquartered in Rockville, MD.
Displays a symbol's price movements over previous years to identify recurring trends.